163263-91-0

Usage

Uses

Used in Pharmaceutical Industry:
2,4-Dichloro-6-(4-Methoxyphenyl)pyrimidine is used as an intermediate in the synthesis of various pharmaceuticals for its potential role in the treatment of different diseases. Its unique structure and properties make it a valuable compound in the development of new drugs.
Used in Agrochemical Industry:
2,4-Dichloro-6-(4-Methoxyphenyl)pyrimidine is used as an intermediate in the synthesis of agrochemicals, particularly in the development of pesticides. Its pesticidal properties have shown potential as a herbicide, making it a valuable compound in the agricultural sector.
Used in Organic Synthesis:
2,4-Dichloro-6-(4-Methoxyphenyl)pyrimidine is used as a building block in organic synthesis, contributing to the creation of various organic compounds. Its unique structure allows for versatile applications in the synthesis of a wide range of organic molecules.
Used in Research Applications:
2,4-Dichloro-6-(4-Methoxyphenyl)pyrimidine is utilized in research for its potential applications in various fields, including the development of new drugs, agrochemicals, and organic compounds. Its unique properties make it a valuable compound for scientific exploration and innovation.

Upstream product

• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 3764-01-0 2,4,6-trichloropyrimidine 
• 13139-86-1 4-methoxyphenyl magnesium bromide 
• 5720-07-0 4-methoxyphenylboronic acid 

Downstream Products

• 163263-90-9 C₂₃H₁₈N₂O₅ 
• 17511-19-2 2,4-diamino-6-(4-methoxyphenyl)-pyrimidine 

Relevant academic research and scientific papers

INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF

A class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

Influenza virus replication inhibitor and application thereof

The invention relates to an influenza virus replication inhibitor and application thereof, and particularly relates to a compound serving as an influenza virus replication inhibitor, a preparation method thereof, a pharmaceutical composition containing the compound, and application of the compound and the pharmaceutical composition to influenza treatment.

INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF

Provided herein is inhibitors of influenza virus replication and uses thereof. Specifically, provided herein a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF

The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF

The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits

In recent years, xanthine oxidase has emerged as an important target not only for gout but also for cardiovascular and metabolic disorders involving hyperuricemia. Contrary to popular belief, recent clinical trials with uricosurics have demonstrated that

A highly regioselective amination of 6-aryl-2,4-dichloropyrimidine

A highly regioselective amination of 6-aryl-2,4-dichloropyrimidine with aliphatic secondary amines and aromatic amines has been developed which strongly favors the formation of the C4-substituted product. The reactions with aliphatic amines are carried ou

NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM

The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.

Coating compositions stabilized against damage by light, heat and oxygen

Coatings comprisingA) a binder based on an organic polymer andB) as stabilizer against damage by light, heat and oxygen, a 2-(2′-hydroxyphenyl)-1,3-pyrimidine of the formula I ?in which the radicals R1 to R6 are as defined in claim 1 have an outstanding resistance to the damaging effects of light, oxygen and heat. Compounds of the formula Ib defined in claim 18 are suitable in general for the stabilization of organic material.

Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants

This invention is directed to aryl and heterocyclyl substituted pyrimidine derivatives selected from the following formulae: wherein Z1, Z2, R1, R2, R3, R4, R5and R6are defined herein. These compounds are useful as anti-coagulants.